Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

Launched by YAN BI · Jan 16, 2024

Keywords

ClinConnect Summary

As soon，metformin、SGLT-2i、GLP-1RA have been confirmed to have protective effect on the kidneys in the statement of consensus at home and abroad. Dorzagliatin exerts a potent hypoglycemic effect by activating glucokinase and is not affected by the patient's renal function. However, previous studies of this drug have rarely involved studies that improve markers related to renal function. On the one hand, in this study, changes of renal function (eGFR, creatinine, cystatin C, TNF-1) are collected to investigate whether dorzagliatin is benefit to kidney. On the other hand, renal magnetic resona...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age:18-75 years old, male and female.
• • 2. Patients with type 2 diabetes mellitus, type 2 diabetes mellitus diagnosis criteria: according to the "Chinese Type 2 Diabetes Mellitus Prevention and Treatment Guide (2020 Edition).
• • 3. UACR 30-299mg/g.
• • 4. eGFR ≥60mL/min/1.73m².
• • 5. HbA1c 7.0-10.5%.
• Exclusion Criteria:
• • 1. Pregnant and lactating women and women of childbearing age who do not want to take reliable contraceptive measures.
• • 2. Known allergic history to dorzagliatin/gliclazide/metformin.
• • 3. Diabetic acute and chronic complications, including diabetic ketoacidosis, a hyperglycemic hyperosmolar state or hypoglycemic coma, etc.
• • 4. Serious impairment of heart, liver, kidney and other organs.
• • 5. With hypertension(≥140/90mmHg).
• • 6. Fasting C-peptide \<300pmol/L.
• • 7. Contraindications of MRI examination, such as implantation of metal prosthesis in vivo, claustrophobia, wearing insulin pumps, etc.